Monitor for additional Form 144 or Form 4 filings by other insiders. The concentrated selling by a former officer over a short period could precede further insider exits or indicate a lack of conviction ahead of upcoming catalysts.
Price Chart
Executive Summary
Former officer Aziz Mottiwala filed a Form 144 to sell 8,000 shares (~$654k) of Tarsus Pharmaceuticals. This follows substantial recent sales of 212,073 shares (~$15.4M) over the prior two weeks. While the proposed sale is small relative to market cap, the pattern of aggressive selling by a former officer may signal reduced confidence.
Key Facts
- Aziz Mottiwala (former officer) intends to sell 8,000 shares of common stock, estimated value $654,373.01.
- Shares were acquired on 07/27/2020 via stock option exercise.
- Mottiwala has already sold 53,043 shares on 08/19/2026, 81,332 shares on 08/25/2026, and 77,698 shares on 09/01/2026 — totaling 212,073 shares (~$15.4M).
- Proposed sale represents ~0.02% of TARS's $3.2B market cap; recent sales total ~0.48%.
Financial Impact
Proposed sale of $654k is small; recent aggregate sales of ~$15.4M are more material and may weigh on sentiment.
Risk Factors
- Further insider selling could pressure the stock.
- The selling pattern may reflect negative private information about the company's outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-006653 |
| Document: 0001959173-26-006653-index.html | 0001959173-26-006653 |
| Document: 0001959173-26-006653.txt | 0001959173-26-006653 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $82.77 $77.64 | ▼ −6.20% | ▼ −5.54% | $74.04 (−10.55%) |
Sep 3, 2026 29d ago | Insider Cluster | $83.21 $79.31 | ▼ −4.68% | ▼ −3.53% | $74.04 (−11.02%) |
Sep 2, 2026 29d ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $74.04 (+10.54%) |
Sep 1, 2026 4w ago | 144 | $82.76 $81.12 | ▲ +1.98% | ▲ +1.02% | $74.04 (+10.54%) |
Aug 19, 2026 6w ago | 144 | $73.44 $70.65 | ▼ −3.80% | ▼ −3.41% | $74.04 (+0.81%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $74.04 (+13.32%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $74.04 (+13.32%) |
Aug 6, 2026 8w ago | 8-K | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $74.04 (+13.32%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $74.04 (+13.32%) |
Aug 6, 2026 8w ago | Press Release | $65.33 $68.88 | ▲ +5.43% | ▲ +4.22% | $74.04 (+13.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access